Latest News and Press Releases
Want to stay updated on the latest news?
-
COMMUNIQUÉ DE PRESSE - INFORMATIONS PRIVILÉGIÉES ET RÉGLEMENTÉES2 août 2022, 16h00 EDT/22h00 CET Mdxhealth acquiert l'activité Oncotype DX® GPS pour le cancer de la prostate d’Exact Scienceset...
-
NEWS RELEASE – INSIDE AND REGULATED INFORMATIONAugust 2, 2022, 4:00PM EDT / 22:00 CET Mdxhealth Acquires Oncotype DX® GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half...
-
COMMUNIQUE DE PRESSE - INFORMATION REGLEMENTEE 25 mai 2022, 16 h 00 EDT/22 h 00 CET MDxHealth annonce les résultats de ses assemblées générales ordinaire et extraordinaire des actionnaires et...
-
NEWS RELEASE - REGULATED INFORMATION 25 May 2022, 4:00 p.m. EDT / 22:00 CET MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings and Resignation...
-
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE19 Mai 2022, 16 h 00 EDT/22 h 00 CET Palmetto GBA émet la couverture LCD de base pour SelectMDx® for Prostate Cancer IRVINE, CA, et...
-
NEWS RELEASE - REGULATED INFORMATIONMay 19, 2022, 4:00PM EDT / 22:00 CET Palmetto GBA’s MolDX Issues Foundational LCD Covering the Indication for SelectMDx® for Prostate Cancer IRVINE,...
-
COMMUNIQUÉ DE PRESSE – INFORMATIONS RÉGLEMENTÉES27 AVRIL 2022, 16 h 00 EDT/22 h 00 CET MDxHealth communique ses résultats du 1er trimestre de l’exercice 2022 IRVINE, CA, et HERSTAL,...
-
NEWS RELEASE - REGULATED INFORMATION27 APRIL 2022, 4:00PM EDT / 22:00 CET MDxHealth Reports Q1-2022 Results IRVINE, CA, and HERSTAL, BELGIUM – April 27, 2022 – MDxHealth SA...
-
COMMUNIQUE DE PRESSE - INFORMATION...
-
NEWS RELEASE - REGULATED INFORMATION 25 April 2022, 10:00 p.m. CET MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings IRVINE, CA, and...